Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2007-06-12
2007-06-12
Badio, Barbara P. (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C540S002000
Reexamination Certificate
active
11048310
ABSTRACT:
Disclosed herein is a paroxetine cholate or cholic acid derivative salt and a composition comprising paroxetine and cholic acid or a derivative thereof. Further disclosed is a pharmaceutical composition comprising the paroxetine salt or the composition. The pharmaceutical composition can be formulated into an oral preparation for swallowing without water as an orally disintegrating tablet for paroxetine.
REFERENCES:
patent: 4721723 (1988-01-01), Barnes et al.
patent: WO 95/20964 (1995-08-01), None
patent: WO 99/32484 (1999-07-01), None
patent: WO 99/40084 (1999-08-01), None
patent: WO 99/52901 (1999-10-01), None
patent: WO 99/55699 (1999-11-01), None
patent: WO 00/01692 (2000-01-01), None
patent: WO 00/01694 (2000-01-01), None
patent: WO 03/013470 (2003-02-01), None
patent: WO 03/013529 (2003-02-01), None
Remeron Sol Tab®— Compliance © 2004 NV Orgamon.
Cholic Acid Product information date needed.
Ki Min Hyo
Kim Bok Young
Lee Hong Woo
Lee Sang Joon
Lee Su Kyoung
Badio Barbara P.
Chong Kun Dang Pharmaceutical Corp.
Jones Day
LandOfFree
Paroxetine cholate or cholic acid derivative salts, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Paroxetine cholate or cholic acid derivative salts, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Paroxetine cholate or cholic acid derivative salts, and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3850818